The whole point of the article is that psychedelics increase neuroplasticity within the brain, and that pharma companies are trying to synthesize a molecule that does exactly that, but without the hallucinations.
Here's the article in question - perhaps there's something I missed that you might understand better than I do: https://www.nytimes.com/2022/07/15/opinion/hallucinations-ps...
The whole point of the article is that psychedelics increase neuroplasticity within the brain, and that pharma companies are trying to synthesize a molecule that does exactly that, but without the hallucinations.
Here's the article in question - perhaps there's something I missed that you might understand better than I do: https://www.nytimes.com/2022/07/15/opinion/hallucinations-ps...